To Cure Together

We’re ADC specialists focused on doing one thing brilliantly.

Outsmarting cancer.

To Cure Together

We’re ADC specialists focused on doing one thing brilliantly.

Outsmarting cancer.

ONE OBJECTIVE.

SINCE 2010.

ADC BIO is an innovative biotechnology company. Specialising in Antibody Drug Conjugates.

We’re developing new process technology. To speed, simplify and significantly lower the production costs of the latest generation of anticancer blockbuster ADC drugs.

JOIN US FOR THE JOURNEY
ADC Bio

TECHNOLOGY

LOCK-RELEASE.

TARGETING DISEASE.
WITH PRECISION.

ADC BIO’s proprietary Lock-Release technology is a fast, simple, cost efficient and robust system to guarantee ADCs of a consistently high quality and purity.

DISCOVER THE BENEFITS

BIO-CONJUGATION SERVICES.

We’re nimble, flexible and focused on helping ADC drug developers bring the next generation of anticancer drugs to life.

3-arrows

NEWS

LIVE WEBINAR: WEDNESDAY, JUNE 12TH AT 8:00 PT / 11:00 ET / 16:00 GMT

  Investing for the Future: Unlocking Advanced ADC Manufacturing Innovation   ADC Bio, Bioscience Managers and Maven Capital Partners analyse compelling market trends in ADC clinical development and factors driving industry investment surge Webinar hosted by ADC Review takes place on 12 June   14 …

READ PRESS RELEASE

CAREERS

GREAT MINDS.
THINKING ALIKE.

JOIN THE TEAM.

WE'RE HIRING